ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Clinical trials for ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) explained in plain language.
Never miss a new study
Get alerted when new ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) trials appear
Sign up with your email to follow new studies for ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New ADHD pill for kids tested in Japan-China joint trial
Symptom relief Recruiting nowThis study tests whether a once-daily capsule called EB-1020 can safely reduce ADHD symptoms in children and adolescents aged 6 to 17. About 315 participants will receive either a low dose, a high dose, or a placebo for 6 weeks. The main goal is to see if symptoms improve using a…
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Phase: PHASE2, PHASE3 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC
-
Could a common ADHD drug also lift depression? new trial investigates
Symptom relief Recruiting nowThis study tests whether two different forms of dexamphetamine (a stimulant) can safely help adults who have both ADHD and moderate to severe depression. About 105 participants will receive either the drug or a placebo. The main goal is to check for side effects and see if the tr…
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Phase: PHASE2 • Sponsor: Prof. Dr. Frank Behrens • Aim: Symptom relief
Last updated May 13, 2026 16:00 UTC
-
Wearable tech reveals hidden links between sleep, exercise, and ADHD
Knowledge-focused Recruiting nowThis study looks at how sleep, physical activity, and daily body rhythms are connected to ADHD symptoms in children. Researchers will use a wristband to track activity and sleep for two weeks, along with brain scans and thinking tests. The goal is to better understand why ADHD af…
Matched conditions: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Phase: NA • Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 01:45 UTC